Differences in gut microbiota structure in patients with stages 4-5 chronic kidney disease/Experiment 1/Signature 1

From BugSigDB
Reviewed Marked as Reviewed by Peace Sandy on 2024-3-27

Curated date: 2024/03/26

Curator: Sneha6003

Revision editor(s): Sneha6003, Peace Sandy

Source: Figure 4

Description: LEfSe analysis was used to statistically resolve the microbiota with significant effects in the different groups. The LDA threshold was set as 2. (A) The stage 4-5 CKD group and (B) the control group.

Abundance in Group 1: increased abundance in Chronic kidney disease

NCBI Quality ControlLinks
Abiotrophia
Acinetobacter
Actinomyces
Actinomycetaceae
Actinomycetales
Actinomycetota
Aerococcaceae
Atopobium
Bacillales
Bacilli
Betaproteobacteria
Burkholderiales
Candidatus Saccharibacteria
Candidatus Saccharibacteria incertae sedis
Carnobacteriaceae
Christensenella
Clostridium
Collinsella
Coprobacillus
Coprobacter
Corynebacteriaceae
Corynebacterium
Eggerthella
Enterobacterales
Enterobacteriaceae
Enterococcaceae
Enterococcus
Erysipelotrichaceae
Erysipelotrichaceae incertae sedis
Erysipelotrichales
Erysipelotrichia
Eubacteriaceae
Eubacterium
Gammaproteobacteria
Gemmiger
Granulicatella
Lactobacillaceae
Lactobacillales
Lactobacillus
Leptotrichia
Micrococcaceae
Moraxellaceae
Morganella
Neisseria
Neisseriaceae
Neisseriales
Olsenella
Paraprevotella
Peptostreptococcaceae
Peptostreptococcus
Pseudomonadaceae
Pseudomonadales
Pseudomonadota
Pseudomonas
Pyramidobacter
Rothia
Ruminococcus
Scardovia
Shuttleworthella
Solobacterium
Staphylococcaceae
Staphylococcus
Streptococcaceae
Streptococcus

Revision editor(s): Sneha6003, Peace Sandy